-
World-leading National Centre for Inflammation Research to be established in Victoria following budget boost
Hudson Institute of Medical Research today welcomed the Victorian Government’s initial investment to kick-start a National Centre for Inflammation Research (NCIR) to be established at the Monash Health Translation Precinct (MHTP) in Melbourne’s growing south-eastern corridor.… Read more
-
ARC Discovery Projects success
Hudson Institute researchers have been awarded more than $2 million from the Australian Research Council Discovery Projects Grant round.… Read more
-
Motor neuron disease inflammation trigger discovered
In collaboration with colleagues at the Walter and Eliza Hall Institute (WEHI) and the University of Melbourne, Hudson Institute scientists have revealed how inflammation in motor neuron disease (MND) is caused,… Read more
-
US President Donald Trump has COVID-19 and is on a cocktail of experimental drugs. What does this mean for his health?
It is unknown how US President Donald Trump will respond to the experimental immunotherapy given to treat his COVID-19 infection, because the drug has not yet been tested and approved, says Hudson Institute Director and CEO, Professor Elizabeth Hartland.… Read more
-
Key to immune system inflammation discovery
Hudson Institute scientists have discovered the key to how cells turn on inflammation and fight infection, providing the knowledge to potentially reduce or stop destructive inflammation in the future.… Read more
-
COVID-19 treatment clinical trial underway
The first clinical trial of a potential COVID-19 treatment involving a discovery by Hudson Institute researchers received approval in September.… Read more
-
Kids thank their scientist superheroes amid pandemic
Olive, 11 and her brother Will, 8 wanted to say a big thank you to their scientist heroes for all their hard work to improve people’s lives, including on COVID-19 research.… Read more
-
Promising target against Australia’s second deadliest cancer
Hudson Institute researchers have identified a target for controlling the development of colon cancer that could lead to novel treatment strategies.… Read more
-
All in your genes: new tool investigates on and off switch for genes
Our genetic material can predispose us to a number of diseases and conditions. Technologies to edit or change our genes are still in their infancy, so scientists are instead looking for ways to use treatments to stop genes that cause health conditions from being turned on.… Read more
-
Could flu deaths be relegated to history?
A drug used in WW II to treat inflammation may hold the key to saving lives in the fight against flu deaths.… Read more
Skip to content
